16 results
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Initiative (PAMI ... #Management # ... Pain #Pharmacology ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Initiative (PAMI ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Initiative (PAMI ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Assessment and Management ... Initiative (PAMI ... #Pain #Pharmacology ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Assessment and Management ... Initiative (PAMI ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Assessment and Management ... Initiative (PAMI ... #Pain #Pharmacology ... Doses #Dosing #Table ... #PAMI
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... Tuberculosis #Drugs #Medications ... #management #pharmacology ... #Table
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
#Prophylaxis #Medications ... #Table #Pharmacology ... #Management #Neurology ... #PrimaryCare
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... suspension 4–6 mL ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology